Influence of LDL receptor gene mutation and apo E polymorphism on lipoprotein response to simvastatin treatment among adolescents with heterozygous familial hypercholesterolemia (Q43889889)

From Wikidata

Jump to navigation Jump to search

scientific article published in February 2002

Language	Label	Description	Also known as
English	Influence of LDL receptor gene mutation and apo E polymorphism on lipoprotein response to simvastatin treatment among adolescents with heterozygous familial hypercholesterolemia	scientific article published in February 2002

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Influence of LDL receptor gene mutation and apo E polymorphism on lipoprotein response to simvastatin treatment among adolescents with heterozygous familial hypercholesterolemia (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

hypercholesterolemia

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Paul-J.‏ ‎Lupien

4

object named as

Paul J Lupien

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

author name string

Marie Claude Vohl

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Francois Szots

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Michel Lelièvre

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Jean Bergeron

5

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Claude Gagné

6

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Patrick Couture

7

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

publication date

1 February 2002

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Atherosclerosis

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

160

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

361-368

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

An exon 4 mutation identified in the majority of South African familial hypercholesterolaemics

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900584-6

7 January 2021

Prevalence of familial hypercholesterolemia in Johannesburg Jews

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900584-6

7 January 2021

Prevalence and geographical distribution of major LDL receptor gene rearrangements in Finland

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900584-6

7 January 2021

Phenotypic expression of familial hypercholesterolaemia in central and southern Tunisia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900584-6

7 January 2021

Homozygous familial hypercholesterolemia among French Canadians in Québec Province

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900584-6

7 January 2021

Detection of a novel mutation (stop 468) in exon 10 of the low-density lipoprotein receptor gene causing familial hypercholesterolemia among French Canadians

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900584-6

7 January 2021

Identification of three mutations in the low-density lipoprotein receptor gene causing familial hypercholesterolemia among French Canadians

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900584-6

7 January 2021

Identification of two novel LDL receptor gene defects in French-Canadian pediatric population: mutational analysis and biochemical studies

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900584-6

7 January 2021

Geographic distribution of French-Canadian low-density lipoprotein receptor gene mutations in the Province of Quebec.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900584-6

7 January 2021

Deletion in the gene for the low-density-lipoprotein receptor in a majority of French Canadians with familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900584-6

7 January 2021

Molecular genetics of the LDL receptor gene in familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900584-6

7 January 2021

Mutations of low-density-lipoprotein-receptor gene, variation in plasma cholesterol, and expression of coronary heart disease in homozygous familial hypercholesterolaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900584-6

7 January 2021

Heterozygous familial hypercholesterolemia in children: low-density lipoprotein receptor mutational analysis and variation in the expression of plasma lipoprotein-lipid concentrations.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900584-6

7 January 2021

Comparison of the effect of two low-density lipoprotein receptor class mutations on coronary heart disease among French-Canadian patients heterozygous for familial hypercholesterolaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900584-6

7 January 2021

Association of specific LDL receptor gene mutations with differential plasma lipoprotein response to simvastatin in young French Canadians with heterozygous familial hypercholesterolemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900584-6

7 January 2021

Lipoprotein-cholesterol distributions in selected North American populations: the lipid research clinics program prevalence study

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900584-6

7 January 2021

Increase in plasma high-density lipoprotein concentration following complete androgen blockage in men with prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900584-6

7 January 2021

Electroimmuno assay

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900584-6

7 January 2021

Common low-density lipoprotein receptor mutations in the French Canadian population

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900584-6

7 January 2021

Rapid restriction fragment analysis for screening four point mutations of the Low-density lipoprotein receptor gene in French Canadians

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900584-6

7 January 2021

Contribution of receptor negative versus receptor defective mutations in the LDL-receptor gene to angiographically assessed coronary artery disease among young (25–49 years) versus middle-aged (50–64 years) men

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900584-6

7 January 2021

The response to lovastatin treatment in patients with heterozygous familial hypercholesterolemia is modulated by apolipoprotein E polymorphism

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900584-6

7 January 2021

Influence of specific mutations at the LDL-receptor gene locus on the response to simvastatin therapy in Afrikaner patients with heterozygous familial hypercholesterolaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900584-6

7 January 2021

Molecular genetic evidence for a founder effect in familial hypercholesterolemia among French Canadians

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900584-6

7 January 2021

Effect of apolipoprotein E and A-IV phenotypes on the low density lipoprotein response to HMG CoA reductase inhibitor therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900584-6

7 January 2021

Abnormal in vivo metabolism of apolipoprotein E4 in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900584-6

7 January 2021

The influence of apolipoprotein E phenotype on the response to lovastatin therapy in patients with heterozygous familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900584-6

7 January 2021

Influence of apo E polymorphism on the response to simvastatin treatment in patients with heterozygous familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900584-6

7 January 2021

Effect of apolipoprotein E polymorphism and XbaI polymorphism of apolipoprotein B on response to lovastatin treatment in familial and non-familial hypercholesterolaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900584-6

7 January 2021

Lack of interaction of apolipoprotein E phenotype with the lipoprotein response to lovastatin or gemfibrozil in patients with primary hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900584-6

7 January 2021

Identifiers

10.1016/S0021-9150(01)00584-6

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43889889&oldid=2104177200"